logo
Select company
Select metric
-74.15%Operating Cash Flow Margin
VS
Market
13
Sector
40
Industry
70
History
51
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -105.87M-74.15%$ 142.77M
3/31/2025$ 500K0.25%$ 197.5M
12/31/2024$ -20.44M-7.66%$ 266.96M
9/30/2024$ -61.98M-20.37%$ 304.34M
6/30/2024$ -54.27M-17.61%$ 308.13M
3/31/2024$ -152.92M-50.66%$ 301.87M
12/31/2023$ -174.88M-67.98%$ 257.24M
9/30/2023$ -261.9M-124.08%$ 211.07M
6/30/2023$ -244.69M-134.5%$ 181.93M
3/31/2023$ -255.81M-139.51%$ 183.36M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) OCF % stands at 28.36%.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average OCF % has been -39.92%.
  • The median OCF % for COHERUS ONCOLOGY INC during this period was -25.47%
  • COHERUS ONCOLOGY INC reached its highest OCF % over the past 5 years at 32.4%.
  • The lowest OCF % recorded by COHERUS ONCOLOGY INC in the same timeframe -139.51%

COHERUS ONCOLOGY INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
MGNX : MACROGENICS INC -43.58%IGMS : IGM BIOSCIENCES INC -107.9%STRO : SUTRO BIOPHARMA INC -238.21%AGEN : AGENUS INC -125.64%ATRA : ATARA BIOTHERAPEUTICS INC -33.88%CELU : CELULARITY INC -5.7%CSBR : CHAMPIONS ONCOLOGY INC 13.49%KPTI : KARYOPHARM THERAPEUTICS INC -74.99%IPSC : CENTURY THERAPEUTICS INC -100.56%IVVD : INVIVYD INC -244.77%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for COHERUS ONCOLOGY INC is calculated as follows: CF - Operations [ $ 138.73M ] / Revenues [ $ 489.26M ]
(=) OCF % [ 28.36% ]

CHRS - Operating Cash Flow Margin, Last 5 years

-139.51%

Minimum

Mar 31, 2023

32.4%

Maximum

Dec 31, 2020

-39.92%

Average

-25.47%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%